"The president's going to say that you drug manufacturers cannot sell here unless you sell there at a higher price. Stop being willing to sell to them at such a low price," Lutnick said."
"I just got the call from [Health Secretary]Bobby Kennedy. I got a call from [CMS Administrator] Mehmet Oz and said, 'OK, let's get to work on this,'" Lutnick said."
"I mean, they're great American companies, but they sell for $1,000 here and $200 overseas. Come on, that's got to change. Let's get them all to 500 bucks and we're all better off," Lutnick said."
The president is pressuring pharmaceutical manufacturers to stop selling drugs at lower prices overseas and to accept international pricing parity, with threatened tariffs to enforce compliance. Letters were sent to CEOs of 17 large companies demanding binding commitments on price reductions, reshoring manufacturing, and direct-to-consumer sales by the end of the month. Executive agencies including the Department of Health and CMS are being mobilized to implement the push. The policy aims to make the EU and other nations pay more for drugs, lowering U.S. consumers' share of R&D costs and potentially saving Medicare, Medicaid and the public about $1 trillion.
Read at Axios
Unable to calculate read time
Collection
[
|
...
]